LAP-BAND AP Early Experience Trial (APEX)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Apollo Endosurgery, Inc.
ClinicalTrials.gov Identifier:
NCT00501085
First received: July 11, 2007
Last updated: September 16, 2014
Last verified: September 2014

July 11, 2007
September 16, 2014
June 2007
August 2013   (final data collection date for primary outcome measure)
Percent Excess Weight Loss (%EWL) [ Time Frame: Baseline to 5 Years ] [ Designated as safety issue: No ]
Subjects' Percent Excess Weight Loss (%EWL) over the 5 year period post LAP-BAND implantation was measured. Excess Weight = Baseline weight - Ideal weight, where ideal weight is based on a BMI of 25 kg/m2.
Not Provided
Complete list of historical versions of study NCT00501085 on ClinicalTrials.gov Archive Site
  • Change in BMI [ Time Frame: Baseline to 5 years ] [ Designated as safety issue: No ]
    The change in subjects' Body Mass Index (BMI) was examined at 5 years post LAP-BAND placement.
  • Change in Satiety [ Time Frame: Baseline to 5 Years ] [ Designated as safety issue: No ]
    Subjects rated their level of hunger, satiety after meals, and desire to eat at all follow-up visits. Level of hunger was rated using a 6-point scale: 0 = not hungry at all to 5 = as hungry as I have ever felt. Satiety after meals was rated using a 6-point scale: 0 = not at all full to 5 = as full as I have ever felt. Desire to eat was rated using a 6-point scale: 0 = no desire at all to 5 = extremely strong desire.
  • Change in Quality of Life [ Time Frame: Baseline to 5 Years ] [ Designated as safety issue: No ]
    Quality of Life was assessed using the Obesity and Weight-Loss Quality of Life Questionnaire (OWL-QOL-17) .
  • Subject Reported Sleepiness (Epworth Sleepiness Scale) [ Time Frame: Baseline to 5 years ] [ Designated as safety issue: No ]
    The Epworth Sleepiness Scale (ESS) is a questionnaire used to determine a subject's level of daytime sleepiness. The questionnaire presents eight situations for subjects to score their level of sleepiness, using a scale from 0 (would never doze or sleep) to 3 (high chance of dozing or sleeping).
Not Provided
Not Provided
Not Provided
 
LAP-BAND AP Early Experience Trial (APEX)
Not Provided

The purpose of this study is to evaluate the LAP-BAND AP System in severely obese patients.

The primary objective of this study was to collect additional information about the safety and effectiveness of the LAP-BAND AP System in a real-life clinical setting. Effectiveness was assessed through the collection of weight loss data, as well as other secondary effectiveness measurements. Safety was assessed by the incidence and severity of adverse events (AEs) related to treatment.

Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Community sample

Obesity, Morbid
Device: LAP-BAND AP Adjustable Gastric Banding System
Reduction of food intake due to creation of smaller stomach pouch.
LAP-BAND
Patients who receive the LAP-BAND AP Adjustable Gastric Banding System.
Intervention: Device: LAP-BAND AP Adjustable Gastric Banding System

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
521
November 2013
August 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patient is scheduled to receive the LAP-BAND AP System
  • Willingness to follow protocol requirements, including: the Informed Consent Form (ICF), Health Insurance Portability and Accountability Act (HIPAA) forms, follow-up schedule, completion of patient questionnaires.

Exclusion Criteria:

  • Per the LAP-BAND AP System Directions For Use (DFU)
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00501085
MedAff-LBAP201
Not Provided
Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc.
Not Provided
Study Director: Apollo Endosurgery Apollo Endosurgery, Inc.
Apollo Endosurgery, Inc.
September 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP